Programme at a glance

Programme at a glance, Paris

Thursday, 4 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
14.30 - 17.00
Actualités et controverses sur l’arthrose et l’ostéoporose
‣ Symposium conjointement organisé par la Société Française de Rhumatologie (SFR), le Groupe de Recherche et d’Informations sur les Ostéoporoses (GRIO), l’International Osteoporosis Foundation (IOF) et l’European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: Leith Zakraoui, Bernard Cortet, Thierry Thomas
‣ 14h30 : Produits laitiers fermentés et santé osseuse Emmanuel Biver
‣ 14h55 : L’arthrose, une histoire d’alimentation ? Jérémie Sellam
‣ 15h20 : L’arthrose, une maladie inflammatoire ? Abdellah El Maghraoui
‣ 15h45 : Vitamine D, arthrose et ostéoporose Etienne Cavalier
‣ 16h10 : L’arthrose rachidienne existe-t-elle ? François Rannou
‣ 16h35 : La place de la vertébroplastie, les données sont-elles solides ? Bernard Cortet
‣ 17h00 : Conclusion Thierry Thomas

Symposium organisé en langue française.

17.30 - 19.30
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons: John A. Kanis, Jean‑Yves Reginster
17.30
Best clinical papers published in 2018
René Rizzoli
18.30
Plenary Lecture: Disease in Art Painting
Davide Lazzeri
19.00
Opening of the meeting
Cyrus Cooper (IOF President, ESCEO Vice‑President)
19.10
Presentation of the 2019 ESCEO Medal of Excellence
19.15
Presentation of the ESCEO-IOF Herbert Fleisch Medal
19.20
Presentation of the IOF Medal of Achievement
19.25
Presentation of the IOF Olof Johnell Science Award
Friday, 5 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
SYMPOSIA
Patients' preferences for anti-osteoarthritis treatment: A cross-European Discrete Choice Experiment: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: Mickaël Hiligsmann, Elaine M. Dennison
‣ 08:00: Welcome and introduction Mickaël Hiligsmann
‣ 08:05: Identification prioritization of important attributes of OA treatment Elaine M. Dennison
‣ 08:20: Results from the cross-European discrete choice experiment Mickaël Hiligsmann
‣ 08:35: Discussion Elaine M. Dennison
‣ 08:55: Conclusion Mickaël Hiligsmann
Osteosarcopenic obesity: enough evidence for a distinct entity: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculo-skeletal Health and Ageing
Chairpersons: Islene Araujo de Carvalho, Roger Fielding
‣ 08:00: Introduction Stefania Maggi
‣ 08:05: Osteosarcopenic obesity: Facts and evidence supporting a distinct entity Jürgen Bauer
‣ 08:20: Osteosarcopenic obesity: Lack of evidence supporting a distinct entity Alfonso Cruz Jentoft
‣ 08:35: Discussion Jürgen Bauer
‣ 08:55: Conclusion Roger Fielding
Panel: Olivier Bruyère, Roland D. Chapurlat, Cyrus Cooper, Alfonso Cruz Jentoft, Elaine M. Dennison, Roger Fielding, John A. Kanis, Jean‑Marc Kaufman, Francesco Landi, Andrea Laslop, Médéa Locquet, Stefania Maggi, Eugene McCloskey, Simone Perna, Jean‑Yves Reginster, René Rizzoli, Yves Rolland, Pawel Szulc, Mila Vlaskovska
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
AVAILABLE INDUSTRY-SPONSORED BREAKFAST SYMPOSIUM
08.00 - 09.00
AVAILABLE INDUSTRY-SPONSORED BREAKFAST SYMPOSIUM
09.00 - 10.30
SCIENTIFIC SESSION I
Chairpersons: John A. Kanis, Jean‑Yves Reginster
09.00
Plenary Lecture 1
‣ When and why use a bone forming agent?
Eugene McCloskey
09.30
Oral communication selected from abstracts
10.20
Presentation of the IOF President's Award
10.30 - 12.10
SCIENTIFIC SESSION II
Chairpersons: René Rizzoli, Cyrus Cooper
10.30
Plenary Lecture 2
‣ Bone fragility and its treatment in chronic renal failure
Peter R. Ebeling
11.00
Oral communication selected from abstracts
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
How to assess frailty in daily practice ?
Evelien Gielen
Disorders of phosphate homeostasis
Maria Luisa Brandi
Pre- and postnatal influences on bone and muscle health in children
Nicholas Harvey
Strengths of recommendations for GIOP management
Jonathan Adachi
14.00 - 15.00
Poster Viewing Session I
14.00 - 15.10
Oral presentation of selected posters
14.00 - 15.00
SYMPOSIA
Reassessment of the safety of anti-osteoarthritis medications: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: Olivier Bruyère, Elaine M. Dennison
‣ 14:00: Welcome and scope of the problem Cyrus Cooper
‣ 14:05: Methodology of the ESCEO Working Group Cyrus Cooper
‣ 14:15: Safety of analgesics, non-steroidal anti-inflammatory drugs and opioids Philip Conaghan
‣ 14:30: Safety of SYSADOAs, intraarticular Hyaluronic Acid and intraarticular corticosteroids Tim McAlindon
‣ 14:45: Discussion Nigel K. Arden
‣ 14:55: Wrap-up and conclusions Nigel K. Arden
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
15.00 - 17.00
SCIENTIFIC SESSION III
Chairpersons: Charlotte Beaudart, Bess Dawson‑Hughes
15.00
Plenary Lecture 3
‣ Early treatment of osteoarthritis
Nigel K. Arden
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 4
‣ Guidelines for the management of osteoarthritis
Jean‑Yves Reginster
15.00 - 16.45
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
‣ Clinical, social, ethical and economic burden of osteoporosis and fragility fractures
16.35
Presentation of the IOF Committee of National Societies Medal
Saturday, 6 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
SYMPOSIUM
Recommendations for the conduct of the economic evaluation in osteoporosis: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) USA branch
Chairpersons: Stuart Silverman, Mickaël Hiligsmann
‣ 08:00: Welcome and scope of the problem Stuart Silverman
‣ 08:05: Recommendations for the conduct of economic evaluations in osteoporosis: a summary from an ESCEO-IOF USA Working Group Mickaël Hiligsmann
‣ 08:20: Challenges, uncertainties and future research agenda for the conduct of economic evaluations in osteoporosis: a summary from an ESCEO-IOF USA Working Group Stuart Silverman
‣ 08:45: Discussion Mickaël Hiligsmann
‣ 08:55: Conclusion Mickaël Hiligsmann
Panel: Susan Bukata, Deborah T.  Gold, Philippe Halbout, Famida Jiwa, Mike Lewiecki, Daniel Pinto, Kenneth Saag, Stuart Silverman, Anna N. A. Tosteson
08.00 - 09.00
AVAILABLE INDUSTRY-SPONSORED BREAKFAST SYMPOSIUM
08.00 - 09.00
AVAILABLE INDUSTRY-SPONSORED BREAKFAST SYMPOSIUM
09.00 - 10.30
SCIENTIFIC SESSION IV
Chairpersons: Thierry Thomas, Stefania Maggi
09.00
Plenary Lecture 5
‣ What spaceflight has taught us regarding bone and muscle
Laurence Vico
09.30
Oral communication selected from abstracts
10.20
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
10.30 - 12.10
SCIENTIFIC SESSION V
Chairpersons: Bernard Cortet, Elaine M. Dennison
10.30
Plenary Lecture 6
‣ Pharmacological agents for the treatment of sarcopenia
Roger Fielding
11.00
Oral communication selected from abstracts
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Local therapies in osteoarthritis management
François Rannou
Vitamin D and osteoarthritis
Tim McAlindon
Fracture Liaison Services: models and fracture risk reduction
Kassim Javaid
14.00 - 15.00
SYMPOSIUM
Diabetes and Osteoarthritis: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculo-skeletal Health and Ageing
Chairpersons: Elaine M. Dennison, Marc Hochberg
‣ 14:00: Introduction Roland D. Chapurlat
‣ 14:05: Impact of diabetes mellitus on osteoarthritis incidence and progression Nicola Veronese
‣ 14:20 Management of osteoarthritis in diabetic patients Daniel Uebelhart
‣ 14:35 Discussion André Scheen, Islene Araujo de Carvalho
‣ 14:55 Conclusion Elaine M. Dennison
Panel: Jaime Branco, Olivier Bruyère, Roland D. Chapurlat, Cyrus Cooper, Elaine M. Dennison, Gabriel Herrero‑Beaumont, Marc Hochberg, Andrea Laslop, Jean‑Yves Reginster, René Rizzoli, Roland Roth, Lucio C. Rovati, André Scheen, Daniel Uebelhart, Nicola Veronese, Mila Vlaskovska
14.00 - 15.00
Poster Viewing Session II
14.00 - 15.10
Oral presentation of selected posters
14.00 - 15.00
Effects of biologics on bone in chronic arthritis
Osvaldo D. Messina
15.00 - 17.00
SCIENTIFIC SESSION VI
Chairpersons: Radmila Matijevic, Fanny Buckinx
15.00
Plenary Lecture 7
‣ Tools for estimating fracture probability
John A. Kanis
15.30
Presentation of the IOF Best Committee of National Societies Booth
15.40
Oral communication selected from abstracts
16.30
Plenary Lecture 8
‣ Osteoporosis screening and fracture risk reduction
Cyrus Cooper
17.00 - 18.30
AVAILABLE INDUSTRY-SPONSORED SYMPOSIUM
17.00 - 18.30
AVAILABLE INDUSTRY-SPONSORED SYMPOSIUM
18.30 - 19.30
NON-SPONSORED SYMPOSIA
Sunday, 7 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
AVAILABLE INDUSTRY-SPONSORED BREAKFAST SYMPOSIUM
08.00 - 09.00
SYMPOSIA
New insights in the management of Osteoarthritis: an update of the ESCEO algorithm for the management of the Osteoarthritis
Chairpersons: François Rannou, Cyrus Cooper
‣ 08:00 Welcome Cyrus Cooper
‣ 08:05 The 2014-2016 ESCEO Algorithm for the management of the Osteoarthritis Olivier Bruyère
‣ 08:15 New insights in the management of Osteoarthritis Cyrus Cooper
‣ 08:30 The updated ESCEO algorithm for the management of knee Osteoarthritis : Assessment of the various treatment modalities by GRADE Nicola Veronese
‣ 8:55 Discussion Roland Roth
Selection of relevant outcomes in sarcopenia: a Discrete Choice Experiment. Outcomes of an ESCEO consensus meeting
Chairpersons: Charlotte Beaudart, Mickaël Hiligsmann
‣ 08:00: Welcome and introduction Mickaël Hiligsmann
‣ 08:05: Identification and prioritization of important outcomes for patients in sarcopenia Charlotte Beaudart
‣ 08:20: Results from the cross-European discrete choice experiment Mickaël Hiligsmann
‣ 08:40: Discussion Alfonso Cruz Jentoft, Islene Araujo de Carvalho
‣ 08:55: Conclusion Charlotte Beaudart
Panel: Jürgen Bauer, Charlotte Beaudart, Olivier Bruyère, Cyrus Cooper, Alfonso Cruz Jentoft, Mickaël Hiligsmann, Francesco Landi, Stefania Maggi, Jean‑Yves Reginster, René Rizzoli, Yves Rolland
08.00 - 09.00
ESPRM-IOF-ESCEO Joint Session
WIN - What is new in Physical and Rehabilitation Medicine on Osteoarthritis
Chairpersons: Fitnat Dincer, Michael Quittan
‣ W.I.N. - What is new in Hand Osteoarthritis? Update in Physical and Rehabilitation Medicine on Hand Osteoarthritis Fitnat Dincer
‣ W.I.N. - What is new in Knee Osteoarthritis? Update in Physical and Rehabilitation Medicine on Knee Osteoarthritis Michael Quittan
‣ W.I.N - What is New in Hip Osteoarthritis? Update in Physical and Rehabilitation Medicine on Hip Osteoarthritis Raquel Valero
09.00 - 10.00
MEET-THE-EXPERT SESSIONS
Obesity, bone and muscle
Roland D. Chapurlat
Androgens: a role in bone and muscle disorders management?
Jean‑Marc Kaufman
Atypical femoral fracture: stage in 2019
Emmanuel Biver
Pitfalls in identification of vertebral fracture
Christian Roux
Muscle strength/power assessment and outcomes
Olivier Bruyère, Charlotte Beaudart
10.00 - 12.00
SCIENTIFIC SESSION VII
Chairpersons: Şansın Tüzün, Famida Jiwa
10.00
Plenary Lecture 9
‣ Vitamin D: how much is too much?
Bess Dawson‑Hughes
10.40
Oral communication selected from abstracts
11.30
Plenary Lecture 10
‣ Dietary protein, dairy and bone: devils or angels?
René Rizzoli
12.00 - 13.00
NON-SPONSORED SYMPOSIA